Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt

Yingst, 2006, Qinghai-like A(H5N1) from domestic cats, northern Iraq, Emerg Infect Dis, 12, 1295, 10.3201/eid1708.060264

World Health Organization (WHO). Clinical management of human infection with avian influenza A(H5N1) virus: http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf.

Aoki, 2007, Influenza virus susceptibility and resistance to oseltamivir, Antiviral Therapy, 12, 603, 10.1177/135965350701200S04.1

Lackenby, 2008, Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe, Euro Surveill, 13, 10.2807/ese.13.05.08026-en

Dharan, 2009, Infection with oseltamivir-resistant influenza A (H1N1) virus in the United States, JAMA, 301, 1034, 10.1001/jama.2009.294

Besselaar TG, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H5N1), South Africa. EID 2008 11 November;14(11):1809-10.

World Health Organization. Influenza A(H5N1) virus resistance to oseltamivir – 2008/2009 influenza season, northern hemisphere: http://www.who.int/csr/disease/influenza/H1N1webupdate20090318%20ed_ns.pdf.

de Jong, 2005, Oseltamivir resistance during treatment of influenza A (H5N1) infection, N Engl J Med, 353, 2667, 10.1056/NEJMoa054512

Le, 2005, Avian flu: isolation of drug-resistant H5N1 virus, Nature, 437, 1108, 10.1038/4371108a

Spackman, 2002, Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes, J. Clin. Microbiol., 40, 3256, 10.1128/JCM.40.9.3256-3260.2002

Payungporn, 2006, Single step multiplex real-time RT-PCR for A(H5N1) influenza A virus detection, J Virol Methods, 131, 143, 10.1016/j.jviromet.2005.08.004

Hall, 1999, BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT, Nucl Acids Symp, 41, 95

Kumar, 2004, MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment, Brief Bioinform, 5, 150, 10.1093/bib/5.2.150

Wetherall, 2003, Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network, J Clin Microbiol, 41, 742, 10.1128/JCM.41.2.742-750.2003

Gubareva, 2002, Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay, Antiviral Research, 53, 47, 10.1016/S0166-3542(01)00192-9

Aymard-Henry, 1973, Influenzavirus neuraminidase and neuraminidase-inhibition test procedures, Bull World Health Organ, 48, 199

Kiso, 2004, Resistant influenza A viruses in children treated with oseltamivir: descriptive study, Lancet, 364, 759, 10.1016/S0140-6736(04)16934-1

Gubareva, 2001, Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir, J Infect Dis, 183, 523, 10.1086/318537

Bright, 2005, Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern, Lancet, 366, 1175, 10.1016/S0140-6736(05)67338-2

Bright, 2006, Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States, JAMA, 295, 891, 10.1001/jama.295.8.joc60020

Deyde, 2007, Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide, J Infect Dis, 196, 249, 10.1086/518936

Barr, 2007, The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006, Antiviral Res, 75, 173, 10.1016/j.antiviral.2007.01.006

Saito, 2007, Amantadine-resistant influenza A (H3N2) virus in Japan, 2005–2006, N Engl J Med, 356, 312, 10.1056/NEJMc062989

Cheung, 2006, Distribution of amantadine-resistant H5N1 avian influenza variants in Asia, J Infect Dis, 193, 1626, 10.1086/504723

Babu, 2000, BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design, J Med Chem, 43, 3482, 10.1021/jm0002679

Treanor, 2000, Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group, JAMA, 283, 1016, 10.1001/jama.283.8.1016

Russell, 2006, The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design, Nature, 443, 45, 10.1038/nature05114

Smith, 2002, Structural studies of the resistance of influenza virus neuramindase to inhibitors, J Med Chem, 45, 2207, 10.1021/jm010528u

Rayner CR, Chanu P, Gieschke R, et al. Population pharmacokinetics of oseltamivir when coadministered with probenecid. J Clin Pharm,. 2008. doi:10.1177/0091270008320317.